AMD Global Telemedicine Inc. (AMD), the leading developer of telehealth solutions for healthcare organizations around the world, integrates MyNICaS™ non-invasive hemodynamic monitoring technology to our AGNES platform. This technology provides a way for remote specialists to treat cardiac patients in place and identify high risk patients before they are symptomatic.
The MyNICaS™ hemodynamic profiling used in telehealth applications allows remote physicians to get an accurate reading of patients’ cardiac output and fluid status to determine treatment right away and improve their clinical outcomes. The reading of stroke volume, cardiac output, cardiac power index, total peripheral resistance and total body water provide remote specialists with the data they need to treat patients in place and avoid exacerbations or hospital readmissions.
Heart failure is one of the most common causes of hospitalization and readmissions. “Putting this type of hemodynamic technology in the hands of clinicians around the world is a game changer,” commented Eric Bacon, President of AMD Global Telemedicine. “And what better way to extend the reach of cardiologists than by adapting this technology for telehealth applications.” Clinical environments that benefit the most from hemodynamic profiling integrated with the AGNES platform include outpatient clinics, heart failure clinics, skilled nursing facilities, nursing homes, and other long-term care facilities.
More information on the hemodynamic monitoring technology for telehealth applications can be found at www.amdtelemedicine.com or contact us at 978-937-9021 to schedule an online demo.
About AMD Global Telemedicine, Inc.
AMD Global Telemedicine (AMD) creates telehealth solutions that empower healthcare organizations to deliver care through digital technology. AMD provides personalized telehealth solutions that connect patients with remote healthcare providers, regardless of location, circumstance, or time. Since 1991, AMD has delivered Telemedicine Encounter Management Solutions to over 10,000 patient end-points in more than 100 countries. For more information on AMD visit www.amdtelemedicine.com.